Ophthalmology Times - Ophthalmology news, articles, and events
WEBEfficacy of novel eye drop to reverse cataracts after phase 1/2 study. By Lynda Charters. August 25th 2024. The drop improves vision by breaking up degraded protein complexes that cause lens clouding. Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
News - Ophthalmology Times
WEBSep 8, 2024 · Retina Society 2024: 12-month outcomes of FARETINA and FARWIDE studies. September 14th 2024. Durga Borkar, MD, sat down with Sydney Crago of Modern Retina to discuss one of her presentations on the 12-month outcomes of the FARETINA and FARWIDE studies from the Retina Society meeting being held this year in …
Myths and misconceptions about autologous serum for dry eye
WEBJun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
FDA approves faricimab-svoa for the treatment of retinal vein …
WEBOct 27, 2023 · Genentech today announced the FDA has approved faricimab-svoa (Vabysmo) for the treatment of macular edema following retinal vein occlusion (RVO). According to a news release 1 from Genentech, a member of the Roche group, RVO is the third indication for faricimab-svoa, in addition to wet, or neovascular, age-related macular degeneration (AMD ...
The dropless future: SLT as a first-line treatment for glaucoma
WEBApr 28, 2020 · Three years later, SLT patients hit their pressure targets at more visits than those with first-line eye drop therapy. Some patients taking drops required glaucoma surgery, but none of the SLT patients did. About 74% of SLT patients required no drops. In addition, in 97% of cases, SLT was more cost-effective than eye drops as a …
Benefits of Monofocal Aspheric Intraocular Lenses
WEBMar 4, 2024 · Pantanelli discusses the potential benefits of using monofocal aspheric IOLs, emphasizing their goal of delivering high-quality vision. Patients can expect excellent distance vision without glasses but may still require them for tasks like reading or computer use. Pantanelli notes that patient satisfaction is high across these options, and the ...
Study suggests potential link between semaglutide and risk of non ...
WEBJul 9, 2024 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively.
Treating chalazion with IPL therapy - Ophthalmology Times
WEBJul 26, 2019 · RELATED: The procedure requires using the IPL system’s smallest tip (8X15 mm2) for precise treatment of the eyelids and the small chalazion lesion. The treatment quickly addresses the burden of bacteria and demodex on the inflamed eyelid and the surrounding tissues, and the inflammatory and vascular components are diminished.
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, pilocarpine HCl ...
Skip to content